The high-risk subsets and low-risk subsets were split into PAM50 molecular subtypes (Parker et al., 2009), respectively, including basal, Her2+, luminal A, luminal B, and triple-negative breast cancer (TNBC), as shown in Figure 9A. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.